Thursday, October 20, 2011

Abattis Insider Buying = Great Things To Come?



Abattis president Withrow acquires 554,000 shares
Ticker Symbol: C:FLU
Abattis president Withrow acquires 554,000 shares
Abattis Biologix Corp (C:FLU)
Shares Issued 52,790,500
Last Close 10/19/2011 $0.055
Thursday October 20 2011 - News Release
Mr. Mike Withrow reports
EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103 IN RESPECT OF THE ACQUISITION OF SHARES OF ABATTIS BIOLOGIX CORP.
Abattis Biologix Corp.'s president, chief executive officer and a director, Michael Withrow, has recently acquired, directly or indirectly, 554,000 common shares of Abattis. Prior to such acquisition, Mr. Withrow held, directly or indirectly or had control over, 3,174,000 common shares, 1,800,000 warrants of Abattis, each of which warrants entitle the holder to acquire one common share in the capital of Abattis. In addition, Mr. Withrow holds an aggregate of 1,500,000 options to acquire 1,500,000 common shares of Abattis. Mr. Withrow currently holds or exercises control or direction over an aggregate of 3,728,000 common shares of Abattis which represent an interest of 6.75% of Abattis' issued and outstanding capital at the date hereof on a non-diluted basis. Assuming the exercise of all warrants and options held by him or over which he has control or direction, Mr. Withrow will hold or exercise control or direction over an aggregate of 7,028,000 common shares of Abattis, which represent an interest of 12.72% of Abattis' issued and outstanding capital at the date hereof, on a partially diluted basis. The securities acquired by Mr. Withrow referred to above are held for investment purposes only. These investments will be reviewed on a continuing basis and holdings may be increased or decreased in the future. On October 17, 2011, the offeror acquired ownership of 1,000 common shares in the capital of Abattis Biologix Corp. The offeror acquired ownership of an additional 5,000 common shares of the Issuer on October 18, 2011.
On October 19, 2011, the offeror acquired ownership of 548,000 common shares in the capital of the Issuer. The 554,000 common shares acquired by the offeror represent approximately 1% of the Issuer's issued common shares. Following the acquisitions referred to in Item 2 above, the offeror owns, directly and indirectly 3,728,000 common shares in the capital of the Issuer representing approximately 6.75% of the Issuer's issued common shares, and owns, directly and indirectly, warrants entitling the purchase of an aggregate 1,800,000 common shares of the Issuer and options entitling the purchase of an aggregate of 1,500,000 common shares, or, assuming exercise of these warrants and options by the offeror, he would own, directly and indirectly, a total of 7,028,000 common shares or approximately 12.72% of the Issuer's issued and outstanding common shares on a partially diluted basis. Of the 554,000 common shares acquired (i) an aggregate of 6,000 common shares were acquired at $0.035/share; (ii) 48,000 common shares were acquired at $0.045/share; and (iii) 500,000 common shares were acquired at a deemed value of $0.05/share. An aggregate of 54,000 common shares were acquired through the facilities of the Canadian National Stock Exchange. The purpose of the offeror and any joint actors in effecting the transaction or occurrence, including any future intention to acquire ownership of, or control over, additional securities of the reporting issuer: In effecting the transaction giving rise to the obligation to file this Report, securities were acquired for investment purposes by the offeror and these security holdings will be evaluated by the offeror and the investment increased or decreased from time to time at the discretion of the offeror.
© 2011 Canjex Publishing Ltd